Titan Pharmaceuticals
TTNP
#10414
Rank
C$8.47 M
Marketcap
C$6.37
Share price
-3.76%
Change (1 day)
20.04%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.51 Million, an increase over its 2023 earnings that were of -C$7.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-39.81%
2024 -C$6.51 Million-15.5%
2023 -C$7.7 Million-45.43%
2022 -C$14.1 Million16.29%
2021 -C$12.13 Million-907.36%
2020 C$1.5 M-106.6%
2019 -C$22.74 Million82.4%
2018 -C$12.47 Million-36.93%
2017 -C$19.77 Million-378.62%
2016 C$7.09 M-145.53%
2015 -C$15.59 Million369.37%
2014 -C$3.32 Million-125.9%
2013 C$12.81 M-177.74%
2012 -C$16.49 Million13.59%
2011 -C$14.52 Million74.37%
2010 -C$8.33 Million3.61%
2009 -C$8.04 Million
2007 -C$25.47 Million12.08%
2006 -C$22.73 Million-28.65%
2005 -C$31.85 Million-10.03%
2004 -C$35.4 Million-6.08%
2003 -C$37.69 Million-14.76%
2002 -C$44.22 Million32.52%
2001 -C$33.37 Million27.55%
2000 -C$26.16 Million62.5%
1999 -C$16.1 Million4.04%
1998 -C$15.48 Million49.33%
1997 -C$10.37 Million-27.88%
1996 -C$14.37 Million13.04%
1995 -C$12.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-C$0.17 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.32 Million 320.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.36 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.68 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
C$36.11 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA